Effective August 18, 2016, Illinois reduced the rate of sales and use tax on "Class III" medical devices prescribed to a patient to treat cancer.
The federal Food and Drug Administration (FDA) divides medical devices into three classes based on the risk associated with using the device. The FDA identifies devices as "Class III" when it believes they carry the highest risks.
The new law reduces the rate of sales and use tax to 1% for Class III devices prescribed to treat cancer. The reduced rate also covers all accessories and parts for those devices.